AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimimark M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sunmarker Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimimark M 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation assists in regulating blood glucose levels. Diabex Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical supervision, risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and how to manage them; maintain regular mealtimes and carry a rapid-acting glucose source. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glimimark M 2mg/500mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful text is required to perform the requested action.

Uses of Glimimark M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimimark M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimimark M 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimimark M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimimark M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. It's recommended to take Glimimark M 2mg/500mg Tablet with a meal.

How Glimimark M 2mg/500mg Tablet works:

Glimepiride and Metformin 2mg/500mg (Glimimark M) tablets combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimimark M 2mg/500mg tablets is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimimark M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimimark M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimimark M 2mg/500mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. The use of Glimimark M 2mg/500mg Tablets is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimimark M 2mg/500mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimimark M 2mg/500mg Tablet :

Should you forget to take your Glimimark M 2mg/500mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication timetable. Never take a double dose.

Facts to Know About Glimimark M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimimark M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimimark M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Glimimark M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glimimark M is not suitable for type 1 DM.
Glimimark M 2mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimimark M 2mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some studies.
Glimimark M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimimark M 2mg/500mg tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, risking hypoglycemia, and may also heighten the risk of lactic acidosis.
Glimimark M 2mg/500mg Tab...
80
MRP 98
17% off